Infliximab Concentrations in Participants with Moderate to Severe COVID-19. uri icon

Overview

publication date

  • November 30, 2023

Research

keywords

  • Antirheumatic Agents
  • COVID-19

Identity

Digital Object Identifier (DOI)

  • 10.1002/jcph.2388

PubMed ID

  • 38031826